Victory Capital Management Inc. Sells 10,493 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Victory Capital Management Inc. trimmed its stake in IQVIA Holdings Inc. (NYSE:IQV) by 10.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 94,670 shares of the medical research company’s stock after selling 10,493 shares during the quarter. Victory Capital Management Inc. owned 0.05% of IQVIA worth $21,905,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of IQV. AdvisorNet Financial Inc boosted its stake in IQVIA by 327.6% in the 4th quarter. AdvisorNet Financial Inc now owns 124 shares of the medical research company’s stock worth $29,000 after purchasing an additional 95 shares in the last quarter. BKM Wealth Management LLC purchased a new stake in shares of IQVIA during the fourth quarter valued at approximately $32,000. Activest Wealth Management bought a new stake in shares of IQVIA during the fourth quarter valued at approximately $35,000. CVA Family Office LLC purchased a new position in IQVIA in the 4th quarter worth approximately $43,000. Finally, CoreFirst Bank & Trust bought a new position in IQVIA in the 3rd quarter valued at approximately $44,000. 89.62% of the stock is owned by hedge funds and other institutional investors.

IQVIA Stock Performance

NYSE:IQV opened at $227.88 on Thursday. The stock has a 50-day simple moving average of $243.28 and a two-hundred day simple moving average of $225.03. The company has a debt-to-equity ratio of 2.02, a quick ratio of 0.88 and a current ratio of 0.88. IQVIA Holdings Inc. has a 52-week low of $167.42 and a 52-week high of $261.73. The firm has a market capitalization of $41.52 billion, a PE ratio of 31.13, a P/E/G ratio of 2.16 and a beta of 1.52.

IQVIA (NYSE:IQV) last released its earnings results on Wednesday, February 14th. The medical research company reported $2.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.82 by $0.02. The company had revenue of $3.87 billion during the quarter, compared to analyst estimates of $3.80 billion. IQVIA had a net margin of 9.01% and a return on equity of 29.17%. The firm’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.54 EPS. Analysts forecast that IQVIA Holdings Inc. will post 10.12 EPS for the current year.

Analyst Upgrades and Downgrades

IQV has been the subject of several recent analyst reports. Leerink Partnrs restated an “outperform” rating on shares of IQVIA in a research note on Monday, February 26th. StockNews.com upgraded shares of IQVIA from a “hold” rating to a “buy” rating in a research note on Friday, February 16th. Truist Financial reduced their price target on shares of IQVIA from $297.00 to $292.00 and set a “buy” rating for the company in a research note on Friday, May 3rd. Evercore ISI decreased their price objective on shares of IQVIA from $275.00 to $250.00 and set an “outperform” rating for the company in a report on Friday, May 3rd. Finally, Robert W. Baird dropped their target price on shares of IQVIA from $254.00 to $245.00 and set a “neutral” rating on the stock in a report on Friday, May 3rd. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $257.57.

Insider Buying and Selling

In other IQVIA news, insider Eric Sherbet sold 1,000 shares of the firm’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $241.50, for a total transaction of $241,500.00. Following the sale, the insider now directly owns 20,836 shares of the company’s stock, valued at $5,031,894. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, insider Ari Bousbib sold 31,678 shares of the firm’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $250.53, for a total transaction of $7,936,289.34. Following the completion of the transaction, the insider now directly owns 796,752 shares of the company’s stock, valued at $199,610,278.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Eric Sherbet sold 1,000 shares of the business’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $241.50, for a total transaction of $241,500.00. Following the completion of the sale, the insider now owns 20,836 shares in the company, valued at approximately $5,031,894. The disclosure for this sale can be found here. In the last quarter, insiders sold 41,285 shares of company stock valued at $10,331,003. Company insiders own 1.60% of the company’s stock.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.